A Multicenter Study of the Efficacy and Safety of Esketamine for Analgesia During Cesarean Section

PHASE4CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

September 18, 2021

Primary Completion Date

September 20, 2022

Study Completion Date

September 30, 2024

Conditions

Fetal or Neonatal Effect of Damage to Placenta From Caesarean Section

Interventions

DRUG

Esketamine

DRUG

Normal saline

2ml normal saline

Trial Locations (1)

Women's Hospital School of Medicine Zhejiang University, Hangzhou

All Listed Sponsors

lead

Women's Hospital School Of Medicine Zhejiang University

OTHER

NCT04548973 - A Multicenter Study of the Efficacy and Safety of Esketamine for Analgesia During Cesarean Section | Biotech Hunter | Biotech Hunter